Stockreport

Spruce Biosciences Secures Up to $50 Million in Growth Capital from Avenue Capital

Spruce Biosciences, Inc.  (SPRB) 
PDF Initial Funding of $15 Million from the First of Four Tranches, Extending Cash Runway into 2027Facility Will Support Advancement and Potential Launch of TA-ERT for the T [Read more]